Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move (TSX-V:
$BEER.V), (CSE: $DIXI_U.C) (OTC: $DXBRF), Wana Brands
Delta, Kelowna, BC –May 28,
2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its potcast
site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/05281BEER-DIXI-DXBRF.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com “potcasts”,
looking at cannabis news, stocks to watch as well as insights from thought
leaders and experts.
In
today’s podcast we look at a few early announcements and I interview our second
Wana Brand’s athlete, ultra-marathon
runner Flavie
Dokken.
Dixie Brands Inc. (CSE: DIXI.U) (OTC: DXBRF), one of the cannabis industry's leading
consumer packaged goods (CPG) companies, has announced that one of its canine supplement products
will form the basis of a clinical trial by the Veterinary Clinical
Investigations Center at the University of Pennsylvania School of Veterinary
Medicine (Penn Vet). The trial will
evaluate the effectiveness of "Mobility," a hemp-based natural
supplement developed by Dixie subsidiary Therabis, to relieve symptoms of joint
immobility in dogs.
Penn
Vet's clinical trial will be led by principal investigator Dr. Kimberly
Agnello. Dogs known to be suffering from inflammation secondary to
osteoarthritis will be studied to determine whether those who receive the
Therabis supplement achieve better outcomes than untreated dogs. One group of
dogs will receive the formula for a proprietary veterinarian-specific formula
Therabis product; a second group will receive Cannabidiol alone which previous
studies have shown may have benefit in osteoarthritic dogs; a control group
will receive a placebo. Study designers are targeting inclusion of up to 20
dogs in each group. The design of this study will provide valuable data
defining the synergistic potential of the additional ingredients in the
Therabis formula.
The
clinical trial is among the first scientific studies of cannabinoid therapy for
pets, and is believed to be the largest-scale trial commenced to date. It is
also believed to be the first major double-blind trial, meaning neither the
researchers nor the dog owners are aware of which subjects are receiving the
placebo or the other two interventions. The study design incorporates physical
tests to establish quantitative measures of effectiveness. In studying dogs'
front leg joints rather than the more commonly studied hips, the trial's
results can be readily extrapolated into other joints since the inflammatory
process is equivalent. Results are anticipated within approximately 12 months,
and are expected to be published in a veterinary medicine journal.
"We
are honored to have a Therabis product selected by the world-renowned experts
at Penn Vet for their first major study of the effects of natural hemp oil to
reduce joint pain in dogs," said Dr. Stephen M. Katz, co-founder of
Therabis. "Our experience in my clinic has shown that cannabidiol (CBD) is
an effective treatment in reducing inflammatory response. We have a passion for
improving dogs' quality of life, and we look forward to learning all we can
about therapeutic methods to achieve this."
Hill Street
Beverage Company Inc. (TSX-V: BEER), announced that it has signed a binding Letter of
Intent to acquire OneLeaf Holding Corp., the parent company of OneLeaf Cannabis
Corp., an "evidence package" stage applicant to become a licensed
cannabis cultivator and processor, in an all share transaction. The Company
also announces a proposed non-brokered private placement of units for gross
proceeds of up to $5 million.
Both
Hill Street and OneLeaf believe that cannabis beverages will expand consumption
of cannabis beyond just the consumer base willing to smoke or vape
products. By combining Hill Street's
award-winning alcohol-free beverages with OneLeaf's access to an award-winning
and unique catalogue of cannabis genetics, the combined company will have the
ability to become a leader in the infused beverages market, in addition to
offering differentiated traditional cannabis products.
"The
OneLeaf team has built a world class, 48,200 square foot facility, built to EU
GMP standards, that will house growing,
extraction, and infusion. It will house the infusion, bottling, and canning of
our beverages under one roof. Their
catalogue of over 700 distinct cannabis cultivars, which have been collected
and cultivated by the founders, includes a collection of Cannabis Cup
award-winning cultivars and a diverse selection of landrace varietals. We
anticipate that OneLeaf's elite genetics, which include many cultivars not
legally available anywhere else, will pair perfectly with our beverages to
provide unique attributes and experiences for our consumers," said Terry
Donnelly, Hill Street's Chairman and CEO.
"We believe the integration of OneLeaf and Hill Street will make
for a powerful force in the market, and positions Hill Street to become a
leading producer of infused beverages and other cannabis products."
"Hill
Street's beverages have already set themselves apart on the world stage,"
said Trevor Green, CEO of OneLeaf. "No other alcohol-free beer and wine
producer has won as many major world championship competitions as Hill Street.
With a complete portfolio of beverages ready for infusion, plus their
demonstrated expertise in private label and branded beverages, we believe the
OneLeaf facility will become a landmark in the industry, and the source of the
finest cannabis infused beverages and other cannabis products in the market.
With our world class cultivation and extraction capabilities, we will be able
to produce unique cannabis cultivars to match both beverage and cannabis
consumption occasions and experiences, whether they are adult format,
nutraceutical, sport-recovery, wellness, or even prescription drug
products."
Cannabis
beverages are the fastest growing segment of the market in US states where they
are legal, according to Headset/Nielsen, growing at up to 61% in the past year.
Each of Hill Street and OneLeaf believe there is a significant opportunity to
grow their brands, as well as provide co-packing services to many companies
wishing to enter the cannabis beverage market but who do not wish to operate
their own packaging and production facilities. This includes major
multinational beverage companies, international cannabis companies looking to
enter the highly regulated Canadian market, and licensed producers looking to
produce beverages using their own cannabis extracts.
Freedom Cannabis
Inc, a Licensed
Producer, is installing a state-of-the-art solar array at its
126,000 square foot facility in Acheson, Alberta, located 20 kilometres west of
Edmonton. The 1,830 kW solar array, supplied by ENMAX, will be Canada's largest
rooftop solar install to-date.
Cannabis
grow facilities consume a great deal of power. The cannabis intel firm New
Frontier Group noted that in 2017, cannabis growers in the US used enough
electricity to power 1.7 million homes, amounting to about 1 per cent of the
entire energy consumption of the United States. And those numbers are only
expected to grow.
"We're
aware of the ecological footprint that comes with cultivating cannabis and we
want to ensure we do our part to protect the environment. This is just our
first step in becoming an industry leader with a commitment to sustainable
initiatives," says Troy Dezwart, Executive Director and Co-Founder of
Freedom Cannabis.
The
solar installation in Acheson is part of Freedom Cannabis's overall commitment
to reducing its impact on the environment. The company incorporates water
remediation programs in its growing process, with the intention of minimizing
waste. It is also exploring BIO fuel alternatives and environmentally friendly
packaging options to further reduce its carbon footprint.
Based
on current demands, the installation is expected to reduce electricity costs by
approximately $200,000 - $300,000 annually and the installation of the array is
expected to be completed by August 2019 and is part of the company's plan to
more than quadruple production by spring 2020.
"Freedom
Cannabis is setting a positive environmental precedent in their industry and
ENMAX is proud to support this organization in delivering on their
environmental commitments," says Jason Atkinson, Director of Solar
Operations at ENMAX, facilitators of the array. Headquartered in Calgary,
Alberta, ENMAX makes, moves and sells electricity to residential, small
business and large commercial customers. To date, they've facilitated 50 per
cent of Alberta's total grid-connected solar.
Speaking
with Wana Brand’s athlete and ultra-marathon
runner Flavie
Dokken, she explained how she utilizes the health benefits of cannabis
as a natural alternative for recovery and pain relief among the athletic
community and beyond.
“Having already utilized cannabis for recovery and pain relief
before becoming a Wana Brand Athlete, I am thrilled to continue our
relationship for a second year,” Dokken said. “Being a Wana ambassador has been
immensely rewarding. I want to educate more people on how cannabis can improve
the quality of their workout. It has certainly helped me be a better athlete.”
A former bodybuilder and a U.S. Army Veteran, Dokken’s many
competitive accomplishments include completing multiple marathons and
ultramarathons such as placing 3rd in the Running Up For Air (RUFA)
- Colorado on March 9 after running up and down Granite Peak for three hours
and three loops for a total 2,700 foot gain and 9.3 miles. Additionally, Dokken
came in 4th out of 110 runners in the Mad Moose Pueblo Half Marathon in
February (pictured), which she completed in under 1 hour and 35 minutes.
Dokken will run as a Wana Athlete brand ambassador in 2019
events including Collegiate Peaks Trail Run (May 4, Buena Vista, Colorado); Speedgoat 50K (July 20, Alta, Utah); Run
the Rut 50K (Sept. 1, Big Sky, Montana); and the
Mad Moose Sage Burner Trail Race 28K (Oct. 26, Gunnison CO).
Many athletes have found that marijuana can be used as a
compliment to their training and recovery programs, and it provides symptom
relief without the negative side effects that painkillers and prescription
drugs can have. It has been reported that Indica strains rich in CBD help
athletes with pain management, relaxation, decreased anxiety and improved sleep
quality.
“Resiliency. Honesty. Integrity. Respect. Optimism. Emotional
Intelligence. Creativity. Transparency. Directness. These are our values and
reflect Flavie’s values – which were made all the more tangible over the past
year,” said Nancy Whiteman, Founder and CEO of Wana Brands. “She knows
first-hand how cannabis is a tool for recovery, and she authentically advocates
for the use of cannabis as a natural remedy among athletes and exercise
enthusiasts alike.”
As cannabis becomes even more mainstream, an increasing number
of athletes are advocating for the use of the herb as a safe and natural
alternative. As a Wana Athlete brand ambassador, Dokken exemplifies how
cannabis can be used as an aid in recovery. Together, Wana Brands and Dokken
will continue to work to educate the athletic community and beyond on how
cannabis can elevate their experience and allow them to enjoy their passion to
the fullest extent.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement
to buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available
on iTunes, Spotify, Google Play Music,
Stitcher, Spreaker, YouTube via
Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment